Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
Myriad Genetics (MYGN) Misses Q3 EPS by 10c
May 5, 2020 4:35 PM EDTMyriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.08), $0.10 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $164 million versus the consensus estimate of $167.19 million.
"We saw several signs of improved business progress in the fiscal third-quarter and test... More
